86 percent success rate in opening the blocked brain blood vessel
Specialists at Stony Brook Medicine’s Cerebrovascular and Stroke Center (CVC) are treating patients with a new generation of blood clot removal devices that show promise in successfully revascularizing stroke patients, including those with large vessel blockages. The Solitaire Flow Restoration Device and the Trevo device, approved by Food and Drug Administration (FDA) in 2012 to treat stroke caused by the sudden obstruction of a brain blood vessel (acute ischemic stroke) showed improved results over a previous standard and first generation clot-removal device in clinical trials.
“We have had excellent outcomes using these new devices,” said David Fiorella, M.D., Ph.D., a Professor of Clinical Neurological Surgery and Radiology at Stony Brook University School of Medicine and Co-Director of the CVC. “In acute ischemic stroke, ‘time is brain,’ and in some cases just minutes matter. Therefore, restoring blood flow in an effective and timely manner is critical to the survival and recovery of stroke patients. These new devices enable us to quickly restore blood flow and retrieve the clot in most patients,” said Dr. Fiorella, who has performed some 30 procedures on stroke patients using the new devices.
“These blot clot removal devices are an important new component of our armamentarium against stroke” said Henry Woo, MD, Professor of Neurological Surgery and Radiology and Co-Director of the CVC, who has also used both devices in patient procedures. “Our center provides endovascular treatment for acute stroke 24/7, and by having the latest technologies to remove brain blood clots, and the expertise to perform endovascular procedures, our Center remains on the cutting-edge against this life-threatening condition.”
According to the American Stroke Association, stroke remains the fourth leading cause of death and leading cause of adult disability in the United States. On average a stroke occurs every 40 seconds in the country, and someone dies from a stroke every four minutes. These statistics speak to the need to develop more effective drugs, devices, and procedures to treat stroke.
Recent results of clinical trials reported in The New England Journal of Medicine (February 2013) about the use of first generation of blood clot removal devices in the endovascular treatment of acute ischemic stroke revealed that endovascular treatment does not result in better patient outcomes compared to standard drug treatments. Dr. Fiorella contends that while these trial results are important in the search for the best treatment protocols for acute ischemic stroke, the new devices and techniques are markedly better than those used to treat the majority of patients in these trials and may yet prove to be the most effective approach in select patients. Further research trials are being conducted at Stony Brook to investigate the efficacy of these newer, better devices in acute ischemic stroke.
The new devices that Stony Brook cerebrovascular specialists use to perform revascularization are expandable wire-mesh systems that collapse and are delivered into the brain blood vessels through small flexible tubes (microcatheters) which are guided from the groin to the brain. The devices open at the site of the clot, displacing the occlusion and immediately restoring blood flow to the brain. When the devices are withdrawn from the blood vessel, they take the clot with them, allowing the clot to be removed from the blood vessel.
The Latest Bing News on:
Stroke treatment
- Heat Stroke: Learn How This Colour Therapy Can Treat Iton April 27, 2024 at 11:30 am
Other strategies for preventing heat stroke include: Monitoring the color of your urine. Darker urine is a sign of dehydration. Be sure to drink enough fluids to maintain very light-colored urine.
- Stroke, hemorrhage, sepsis: Idaho doctors detail ways abortion ban risks patients’ healthon April 27, 2024 at 5:58 am
Dr. Becky Uranga has always loved working in emergency obstetrics. As an OB-GYN, she and her colleagues at OGA Women’s Health rotate emergency shifts, when Uranga spends 24 hours coveri ...
- FDA approves first treatment to reduce risk of serious heart problems specifically in adults with obesity or overweighton April 26, 2024 at 9:58 am
The U.S. Food and Drug Administration recently approved a new indication for use for Wegovy (semaglutide) injection to reduce the risk of cardiovascular death, heart attack and stroke in adults with ...
- How to spot the signs of a stroke using the F.A.S.T acronymon April 26, 2024 at 6:00 am
ABC News medical correspondent Dr. Darien Sutton uses an American Heart Association tool to show what face drooping would look like during a stroke.
- Why employers should prioritize stroke prevention in the workplaceon April 25, 2024 at 3:16 pm
A stroke rehabilitation specialist explains the risk factors women face, and how certain lifestyle changes can keep them healthy.
- Mom Gives Birth, Suffers Near-Fatal Stroke Hours Later Due to Undetected Heart Defect: ‘Ticking Time Bomb’on April 25, 2024 at 6:17 am
California native Christina Aleksanian is lucky to be alive after she had a stroke hours after giving birth to her third daughter and was rushed to the operating room where doctors removed a blood ...
- ACTICOR BIOTECH: Topline Results of ACTISAVE Phase 2/3 Study in Stroke Treatmenton April 24, 2024 at 11:00 pm
ACTICOR BIOTECH (FR0014005OJ5 - ALACT) (Paris:ALACT), a clinical-stage biotechnology company focused on the development of glenzocimab, an innovative drug for the treatment of cardiovascular ...
- Stroke Recovery: A Timelineon April 24, 2024 at 9:00 pm
How much progress a person can make and the timeline for their recovery depend on the type and location of the stroke and the patient’s age and overall health, says Richard Harvey, M.D., clinical ...
- Teleneurology for Suspected Stroke Speeds Treatmenton April 24, 2024 at 6:30 am
Alerting neurologists via telemedicine that a patient with suspected acute stroke is en route to the hospital significantly speeds thrombolytic treatment.
- Federal grant to advance brain stroke researchon April 23, 2024 at 5:00 pm
Kaveh Laksari, a UC Riverside assistant professor of mechanical engineering, was awarded $3 million from the National Institutes of Health to develop predictive models for stroke treatment strategies ...
The Latest Google Headlines on:
Stroke treatment
[google_news title=”” keyword=”stroke treatment” num_posts=”10″ blurb_length=”0″ show_thumb=”left”] [/vc_column_text]The Latest Bing News on:
Blood clot removal devices
- Why Do I Have Blue Fingernails?on April 26, 2024 at 3:00 am
Cyanosis is a medical term for bluish discoloration of the skin and nails. It occurs when there is too little oxygen circulating in your blood. It's especially noticeable in areas where many blood ...
- Penumbra's (PEN) New Launch to Enhance Blood Clot Removalon April 24, 2024 at 8:44 am
Penumbra's (PEN) latest offering is likely to enable physicians to restore blood flow more quickly and further minimize blood loss.
- Purdue Innovates Incubator awards $18,500 in cash prizes to Purdue student entrepreneurson April 23, 2024 at 11:25 am
Startup companies led by Purdue University students — Emboa Medical, uChef and Maytik — won $18,500 in cash prizes during the 2024 New Venture Challenge organized by Purdue Innovates Incubator.
- FDA clears computer-assisted thrombectomy system from Penumbraon April 23, 2024 at 10:59 am
Penumbra announced today that it received FDA clearance for and began the launch of its Lightning Flash 2.0 CAVT system.
- Penumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clotson April 23, 2024 at 6:00 am
Penumbra, Inc. (NYSE: PEN), the world's largest thrombectomy company, announced the U.S. Food and Drug Administration (FDA) clearance and launch of Lightning Flash™ 2.0, the next generation computer ...
- Inside the science of strokeson April 23, 2024 at 4:27 am
Johnson & Johnson set off on a mission to revolutionize the study of blood clots. The goal was to figure out how different clot characteristics—like size, composition ...
- CERENOVUS launches catheter to treat acute ischemic strokeon April 23, 2024 at 3:31 am
CERENOVUS, part of Johnson & Johnson MedTech, has launched CEREGLIDE 71 Aspiration Catheter in Europe, an aspiration catheter equipped with TruCourse technology, indicated for the revascularisation of ...
- Univ. of Iowa Hospitals and Clinics completes 500 procedures using blood thinner alternativeon April 22, 2024 at 8:55 pm
Because some patients aren’t able to tolerate blood thinners in the long-term, this procedure is able to lower the risk of strokes just the same.
- Thousands dead, 40 years of cover-up: time for justice for infected blood victimson April 20, 2024 at 10:00 am
NHS doctors used haemophiliac children for reckless medical experiments. Decades on, many grieving families have never received a penny in compensation and the state has never taken responsibility. To ...
- The Best Compression Socks For Travel, According To A Podiatriston April 16, 2024 at 12:45 pm
After reviewing many pairs with Dr. Nelya Lobkova, DPM, we selected Trtl Compression Socks as the best travel compression socks. Here's what else made our list.
The Latest Google Headlines on:
Blood clot removal devices
[google_news title=”” keyword=”blood clot removal devices” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]